http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5814640-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66a3c73049079eaff72daf3308fcf42b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-215 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate | 1997-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1998-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6f16ddf547bc33977020d8684186c7d |
| publicationDate | 1998-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5814640-A |
| titleOfInvention | Method of treating gastrointestinal malignancies |
| abstract | The present invention provides a method for the treatment of carcinoma. Those carcinomas include those of visceral origin and in particular gastrointestinal malignancies. The method comprises administering an amount of 5-fluorouracil and an amount of interferon which is effective in the palliation of said carcinoma or malignancy. Alpha, beta or gamma interferon may be used but recombinant alpha-2a-interferon is preferred. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007051431-A2 |
| priorityDate | 1994-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.